Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 763-768

  Galligan, Leeona ^a   Catherwood, Mark ^a,b   Matthews, Christine ^a   Morris, T C M Curly ^a   Alexander, Dennis H ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

CDR3; CLL; IgHV gene usage; Prognosis; Somatic hypermutation

Indexed keywords

ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ANTIGEN EXPRESSION; CANCER CHEMOTHERAPY; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; COMPLEMENTARITY DETERMINING REGION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SOMATIC HYPERMUTATION;

AMINO ACID SEQUENCE; ANTIGENS, CD38; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENE FREQUENCY; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MUTATION; PROGNOSIS;

EID: 42049087270     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190801911696     Document Type: Conference Paper

References (30)

1. Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. and Stevenson, F. K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, pp. 1848-1854.
2. Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A. and Allen, S. L. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, pp. 1840-1847.
3. Durig, J., Nuckel, H., Cremer, M., Führer, A., Halfmeyer, K. and Fandrey, J. (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia, 17, pp. 2426-2434.
4. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D. and Rozman, M. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med, 348, pp. 1764-1775.
5. Orchard, J. A., Ibbotson, R. E., Davis, Z., Wiestner, A., Rosenwald, A. and Thomas, P. W. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, pp. 105-111.
6. Catherwood, M. A., Matthews, C., Niblock, R., Dobbin, E., Morris, T. C. and Alexander, H. D. (2006) ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haematol, 76, pp. 294-298.
7. Hayat, A., O'Brien, D., O'Rourke, P., McGuckin, S., Fitzgerald, T. and Conneally, E. (2006) CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leuk Lymphoma, 47, pp. 2371-2379.
8. Krober, A., Seiler, T., Benner, A., Bullinger, L., Brückle, E. and Lichter, P. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, pp. 1410-1416.
9. Oppezzo, P., Vasconcelos, Y., Settegrana, C., Jeannel, D., Vuillier, F. and Legarff-Tavernier, M. (2005) The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood, 106, pp. 650-657.
10. Buhl, A. M., Jurlander, J., Jørgensen, F. S., Ottesen, A. M., Cowland, J. B. and Gjerdrum, L. M. (2006) Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Blood, 107, pp. 2904-2911.
11. Tobin, G. (2005) The immunoglobulin genes and chronic lymphocytic leukemia (CLL). Ups J Med Sci, 110, pp. 97-113.
12. Tobin, G., Soderberg, O., Thunberg, U. and Rosenquist, R. (2004) V(H)3-21 gene usage in chronic lymphocytic leukemia - characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma, 45, pp. 221-228.
13. Matthews, C., Catherwood, M. A., Morris, T. C. and Alexander, H. D. (2007) V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res, 31, pp. 231-234.
14. Guarini, A., Gaidano, G., Mauro, F. R., Capello, D., Mancini, F. and De Propris, M. S. (2003) Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood, 102, pp. 1035-1041.
15. Capello, D., Guarini, A., Berra, E., Mauro, F. R., Rossi, D. and Ghia, E. (2004) Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia, 8, pp. 1941-1947.
16. Capello, D., Zucchetto, A., Degan, M., Bomben, R., Bo, M Dal and Efremov, D. G. (2006) Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Res, 30, pp. 1197-1199.
17. Tobin, G., Thunberg, U., Karlsson, K., Murray, F., Laurell, A. and Willander, K. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood, 104, pp. 2879-2885.
18. GF, I I Widhopf, Rassenti, L. Z., Toy, T. L., Gribben, J. G., Wierda, W. G. and Kipps, T. J. (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood, 104, pp. 2499-2504.
19. Messmer, B. T., Albesiano, E., Efremov, D. G., Ghiotto, F., Allen, S. L. and Kolitz, J. (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med, 200, pp. 519-525.
20. Murray, F., Darzentas, N., Hadzidimitriou, A., Tobin, G., Boudjogra, M. and Scielzo, C. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: Implications for the role of antigen selection in leukemogenesis. Blood, 21, pp. 2537-2538.
21. Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G. and Smilevska, T. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood, 109, pp. 259-270.
22. Walewska, R., Majid, A., Davis, Z., Dusanjh, P., Kennedy, D. B. and Oscier, D. G. (2007) Male preponderance in chronic lymphocytic leukaemia utilizing IgHV 1-69. Leukemia, 21, pp. 2537-2538.
23. Mauerer, K., Zahrieh, D., Gorgun, G., Li, A., Zhou, J. and Ansén, S. (2005) Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Haematol, 129, pp. 499-510.
24. Kienle, D., Benner, A., Krober, A., Winkler, D., Mertens, D. and Bühler, A. (2006) Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood, 107, pp. 2090-2093.
25. Panovska-Stavridis, I., Ivanovski, M., Siljanovski, N., Cevreska, L. and Efremov, D. G. (2007) Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes. Leuk Res, 31, pp. 245-248.
26. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A. and Allen, S. L. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest, 102, pp. 1515-1525.
27. van Dongen, J. J., Langerak, A. W., Bruggemann, M., Evans, P. A., Hummel, M. and Lavender, F. L. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 17, pp. 2257-2317.
28. Duke, V. M., Gandini, D., Sherrington, P. D., Lin, K., Heelan, B. and Amlot, P. (2003) V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica, 88, pp. 1259-1271.
29. Potter, K. N., Orchard, J., Critchley, E., Mockridge, C. I., Jose, A. and Stevenson, F. K. (2003) Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood, 101, pp. 3082-3084.
30. Marasca, R., Vaccari, P., Luppi, M., Zucchini, P., Castelli, I. and Barozzi, P. (2001) Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol, 159, pp. 253-261.